The first 100 days in office sets the tone for any new president. Similarly, Motley Fool CAPS keeps an eye on how well investors do in their first 100 days. Some of our best -- we call them All-Stars -- have achieved scores of 100 on stock selections in their first 100 days on CAPS. In this column, we're looking at our best players who made some great stock selections early on and seeing which ones they think will be best next.

One of our highest rated CAPS members is wolfersmith, who sports an impressive 99.85 member rating. A member since November 2006, wolfersmith currently has 105 active picks on CAPS out of more than 1,160 stock picks made. Achieving 82% accuracy, wolfersmith has also already attracted 63 "groupies," CAPS players who've listed this leading investor as one of their favorites.

Here are a few of this top member's most recent stock selections and how they were rated.

Stock

CAPS Rating (5 max)

Call

Price^

Current Score^

AEGON

*

Underperform

$3.20

(96.88)

Anadys Pharmaceuticals (NASDAQ:ANDS)

*

Outperform

$5.95

(8.15)

Brown Shoe

*

Underperform

$2.28

(14.32)

Central Gold Trust (NYSE:GTU)

**

Outperform

$46.98

(7.63)

DineEquity

*

Underperform

$5.79

(53.10)

Indevus Pharmaceuticals (NASDAQ:IDEV)

***

Outperform

$5.60

(5.33)

Stone Energy (NYSE:SGY)

***

Underperform

$1.67

(63.95)

Sturm, Ruger (NYSE:RGR)

***

Outperform

$10.17

(7.09)

SXC Health Solutions (NASDAQ:SXCI)

*****

Outperform

$20.81

(9.71)

TeleCommunication Systems (NASDAQ:TSYS)

****

Outperform

$8.14

(1.14)

Source: Motley Fool CAPS.
^Price when call was made. Current score is how many points a member is beating (lagging) the S&P 500 index, from the time of the call.

Let's take a look at what other CAPS members are saying about one of these stocks and whether they agree with this top player's assessment.

Degree of risk
After seeing how the government has dealt with the financial industry, will taxpayers be willing to support plans to have the government run health care?

Even if nationalized health care doesn't happen, there are other aspects of President Obama's proposed overhaul which should probably see the light of day, such as his push for medical records to go digital. One company to benefit from that is health-care IT provider SXC Health Solutions. The software provider helps companies better manage their prescription drug plans, and it also provides practice-management software for pharmacies and others in the prescription drug market.

The company's most recent quarterly net income was driven 31% higher with the help of acquisitions it made over the past year. The purchase of National Medical Health Card Systems gave it an established mail order and specialty pharmaceuticals business covering 2.3 million people. Revenue shot up to $292.8 million, from $23.6 million. The key now will be to finish integrating the business smoothly into its own operations. Growth by acquisition is the easy part; now that it will be lapping the purchase date in May, we'll see if it can turn that into organic growth.

CAPS member SIP08USU believes the IT solutions provider won't have a problem, as it will be able to capitalize on the aging baby boomers:

SXC Health Solutions is one of the leading stocks in a leading industry. They are currently hitting 52-week highs and are a great company fundamentally. They have a lower Return on Equity of only 8.82%. ... They provide pharmacy benefit management services and health care information technology solutions. They are a great company that will capitalize immensely from our very large, aging, baby boomer population.

A 1-in-100 opportunity
Some of the best and smartest members in the CAPS investor-intelligence community have made their mark, but it pays to start your own research on these stocks on Motley Fool CAPS. Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made -- all from a stock's CAPS page.

As hockey great Wayne Gretzky once noted, "You miss 100% of the shots you never take." At Motley Fool CAPS, every investor's opinion counts and since it's free to sign up, why not use this opportunity to take your best shot?

Fool contributor Rich Duprey does not have a financial position in any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool has a disclosure policy.